Prostate Cancer Screening Decision Aides

ACPM received funding from the National Center for Chronic Disease Prevention and Health Promotion to develop materials that promote and enhance informed decision making for men considering prostate cancer screening decisions and their providers.

The decision aids:

  • Incorporate information about benefits and harms of screening, and patient values
  • Include consideration of individual patient risks
  • Facilitate a dialogue among patients and their providers to promote shared decision making based on best available information regarding benefits, harms, and individual risks
  • Include tools and materials for both providers and patients

PrintABLE Guides

The patient Decision Guide is available for providers to print and use. 

Decision Guide

The accompanying Provider Guide includes updated evidence about the potential benefits and harms of screening with the PSA test and helps prepare primary care physicians for discussions with patients.  

Provider Guide

Pilot Test Study

ACPM embarked on a pilot test study of the decision aid tool at Duke University to determine the impact of the decision aid tool on the shared decision making process between a patient and provider when deciding on prostate-specific antigen (PSA) screening for prostate cancer. The pilot study was designed to allow refinement of the decision aid tool and collect necessary preliminary data to enhance the tool’s impact and usability. The overarching goal was to minimize decisional conflict as men make an informed and shared decision regarding prostate cancer screening.

Expert Panel

ACPM and CDC assembled a small panel of experts to serve as advisers to the project. The panel includes experts in prostate cancer and decision aids to discuss current evidence and content in developing decision aids; in patient communication to examine options for modality (web app, videos, devices, etc.) and discuss considerations related to patient communication, health literacy, etc.; and in representing the clinical provider community to discuss needs, facilitators, and barriers to providers using decision aids in primary care settings. Panel members include:

  • Michael Halpern, MD, MPH
  • Kevin Sherin, MD, MPH, MBA
  • Philip Haddad, MD
  • John Ragsdale, MD
  • Daniel George, MD
  • Robert Volk, MD
  • Kathryn Taylor, PhD
  • Andrew Wolf, MD
  • Daniel Blumenthal, MD, MPH


455 Massachusetts Ave. NW. Suite 200
Washington, DC 20001

(202) 466-2044